Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 1;8(7):e2522754.
doi: 10.1001/jamanetworkopen.2025.22754.

Germline Genetic Testing in Patients With Solid Malignant Tumors

Matthew E Fine  1 , Adina Estrin  2   3 , Alissa Michel  1   4 , Vicky Ro  1 , Tarsha Jones  5 , Meghna S Trivedi  1   4 , Katherine D Crew  1   2   4
Affiliations

Germline Genetic Testing in Patients With Solid Malignant Tumors

Matthew E Fine et al. JAMA Netw Open. .
No abstract available

Plain language summary

This cohort study analyzes the clinical and demographic characteristics of patients with cancer who undergo germline genetic testing.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fine reported receiving grants from National Institutes of Health, National Cancer Institute. Dr Estrin reported receiving funding from Aetion, Inc as a former employee and GSK as a current employee. Dr Trivedi reported receiving grants from Lilly, Phoenix Molecular Designs, AstraZeneca, Regeneron, Merck, Novartis, as well as fromGilead Sciences outside the submitted worked Crew reported receiving funding from National Institutes of Health during the conduct of the study. No other disclosures were reported.

References

    1. Daly MB, Pal T, Berry MP, et al. Genetic/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2021;19(1):77-102. doi: 10.6004/jnccn.2021.0001 - DOI - PubMed
    1. Tung N, Ricker C, Messersmith H, et al. Selection of germline genetic testing panels in patients with cancer: ASCO guideline. J Clin Oncol. 2024;42(21):2599-2615. doi: 10.1200/JCO.24.00662 - DOI - PubMed
    1. McCuaig JM, Thain E, Malcolmson J, Keshavarzi S, Armel SR, Kim RH. A comparison of patient-reported outcomes following consent for genetic testing using an oncologist- or genetic counselor-mediated model of care. Curr Oncol. 2021;28(2):1459-1471. doi: 10.3390/curroncol28020138 - DOI - PMC - PubMed
    1. Kurian AW, Li Y, Hamilton AS, et al. Gaps in incorporating germline genetic testing into treatment decision-making for early-stage breast cancer. J Clin Oncol. 2017;35(20):2232-2239. doi: 10.1200/JCO.2016.71.6480 - DOI - PMC - PubMed
    1. Kurian AW, Abrahamse P, Furgal A, et al. Germline genetic testing after cancer diagnosis. JAMA. 2023;330(1):43-51. doi: 10.1001/jama.2023.9526 - DOI - PMC - PubMed